A. Schilling, R. Corey, and M. Leonard, Acetaminophen: old drug, new warnings, Cleve Clin J Med, vol.77, issue.1, pp.19-27, 2010.

A. Michaut, C. Moreau, and M. A. Robin, Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease, Liver Int, vol.34, issue.7, pp.171-180, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01128195

Y. Ishitsuka, Y. Kondo, and D. Kadowaki, Toxicological property of acetaminophen: The dark side of a safe antipyretic/analgesic drug?, Biol Pharm Bull, vol.43, issue.2, pp.195-206, 2020.

R. P. Myers, A. A. Shaheen, and B. Li, Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose, Clin Gastroenterol Hepatol, vol.6, issue.8, pp.918-943, 2008.

R. E. Ferner, J. W. Dear, and D. N. Bateman, Management of paracetamol poisoning, BMJ, vol.342, 2011.

S. S. Lee, J. T. Buters, and T. Pineau, Role of CYP2E1 in the hepatotoxicity of acetaminophen, J Biol Chem, vol.271, issue.20, pp.12063-12070, 1996.
URL : https://hal.archives-ouvertes.fr/hal-02698817

F. P. Guengerich, Cytochrome P450 2E1 and its roles in disease, Chem Biol Interact, vol.322, p.109056, 2020.

B. Fromenty, Alteration of mitochondrial DNA homeostasis in drug-induced liver injury, Food Chem Toxicol, vol.135, p.110916, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02365039

A. Ramachandran and H. Jaeschke, A mitochondrial journey through acetaminophen hepatotoxicity, Food Chem Toxicol, vol.140, p.111282, 2020.

J. E. Laine, S. Auriola, and M. Pasanen, Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes, Xenobiotica, vol.39, issue.1, pp.11-21, 2009.

L. Knockaert, B. Fromenty, and M. A. Robin, Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity, FEBS J, vol.278, issue.22, pp.4252-60, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00739827

L. Knockaert, V. Descatoire, and N. Vadrot, Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen, Toxicol In Vitro, vol.25, issue.2, pp.475-84, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00739823

R. Yang and T. I. Tonnesseen, DAMPs and sterile inflammation in drug hepatotoxicity, Hepatol Int, vol.13, issue.1, pp.42-50, 2019.

H. Jaeschke and A. Ramachandran, Mechanisms and pathophysiological significance of sterile inflammation during acetaminophen hepatotoxicity, Food Chem Toxicol, vol.138, p.111240, 2020.

B. Bhushan and U. Apte, Liver regeneration after acetaminophen hepatotoxicity: mechanisms and therapeutic opportunities, Am J Pathol, vol.189, issue.4, pp.719-748, 2019.

H. B. El-serag and J. E. Everhart, Diabetes increases the risk of acute hepatic failure, Gastroenterology, vol.122, issue.7, pp.1822-1830, 2002.

N. Chalasani, R. J. Fontana, and H. L. Bonkovsky, Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States, Gastroenterology, vol.135, issue.6, pp.1924-1958, 2008.

D. R. Ganger, J. Rule, and J. Rakela, Acute liver failure of indeterminate etiology: A comprehensive systematic approach by an expert committee to establish causality, Am J Gastroenterol, vol.113, issue.9, p.1319, 2018.

R. T. Stravitz and W. M. Lee, Acute liver failure, Lancet, vol.394, pp.869-81, 2019.

Q. Wang, S. Wei, and H. Zhou, Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK/PI3K/AKT-mediated oxidative stress, Cell Death Discov, vol.5, p.119, 2019.

M. C. Deeds, J. M. Anderson, and A. S. Armstrong, Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models, Lab Anim, vol.45, issue.3, pp.131-171, 2011.

M. Radenkovi?, M. Stojanovi?, and M. Prostran, Experimental diabetes induced by alloxan and streptozotocin: The current state of the art, J Pharmacol Toxicol Methods, vol.78, pp.13-31, 2016.

H. M. Wilson, SOCS proteins in macrophage polarization and function, Front Immunol, vol.5, p.357, 2014.

G. R. Steinberg and D. Carling, AMP-activated protein kinase: the current landscape for drug development, Nat Rev Drug Discov, vol.18, issue.7, pp.527-51, 2019.

C. Ioannides, S. L. Bass, and A. D. Ayrton, Streptozotocin-induced diabetes modulates the metabolic activation of chemical carcinogens, Chem Biol Interact, vol.68, pp.189-202, 1988.

D. Wu and A. I. Cederbaum, Combined effects of streptozotocin-induced diabetes plus 4-methylpyrazole treatment on rat liver cytochrome P4502E1, Arch Biochem Biophys, vol.302, issue.1, pp.175-82, 1993.

T. Sakuma, R. Honma, and S. Maguchi, Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat, Xenobiotica, vol.31, issue.4, pp.223-260, 2001.

H. Raza, S. K. Prabu, and M. A. Robin, Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress, Diabetes, vol.53, issue.1, pp.185-94, 2004.

R. K. Sindhu, J. R. Koo, and K. K. Sindhu, Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats, Free Radic Res, vol.40, issue.9, pp.921-929, 2006.

A. Miyamoto, M. Takeshita, and H. Pan-hou, Hepatic changes in adenine nucleotide levels and adenosine 3'-monophosphate forming enzyme in streptozotocin-induced diabetic mice, J Toxicol Sci, vol.33, issue.2, pp.209-226, 2008.

O. Maksymchuk, A. Shysh, and I. Rosohatska, Quercetin prevents type 1 diabetic liver damage through inhibition of CYP2E1, Pharmacol Rep, vol.69, issue.6, pp.1386-1392, 2017.

A. Moncion, N. T. Truong, and A. Garrone, Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin, J Biol Chem, vol.277, issue.48, pp.45904-45914, 2002.

K. J. Woodcroft, M. S. Hafner, and R. F. Novak, Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression, Hepatology, vol.35, issue.2, pp.263-73, 2002.

A. Michaut, L. Guillou, D. Moreau, and C. , A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen, Toxicol Appl Pharmacol, vol.292, pp.40-55, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01255826

B. J. Song, R. L. Veech, and S. S. Park, Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization, J Biol Chem, vol.264, issue.6, pp.3568-72, 1989.

P. G. Forkert, Z. M. Redza, and S. Mangos, Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration, Drug Metab Dispos, vol.22, issue.2, pp.248-53, 1994.

M. A. Abdelmegeed, N. J. Carruthers, and K. J. Woodcroft, Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes, J Pharmacol Exp Ther, vol.315, issue.1, pp.203-216, 2005.

K. Swaminathan, S. M. Kumar, and D. L. Clemens, Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 overexpressing VL-17A cells, Biochim Biophys Acta, vol.1830, issue.10, pp.4407-4423, 2013.

M. D. Davidson, K. R. Ballinger, and S. R. Khetani, Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes, Sci Rep, vol.6, p.28178, 2016.

L. S. Phillips, A. C. Fusco, and T. G. Unterman, Nutrition and somatomedin. XIV. Altered levels of somatomedins and somatomedin inhibitors in rats with streptozotocin-induced diabetes, Metabolism, vol.34, issue.8, pp.765-70, 1985.

L. E. Nagy and N. Kretchmer, Effect of diabetic ketosis on jejunal glutaminase, Arch Biochem Biophys, vol.248, issue.1, pp.80-88, 1986.

K. Motyl and L. R. Mccabe, Streptozotocin, type I diabetes severity and bone, Biol Proced Online, vol.11, pp.296-315, 2009.

V. F. Price and D. J. Jollow, Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity, J Pharmacol Exp Ther, vol.220, issue.3, pp.504-517, 1982.

K. Shankar, V. S. Vaidya, and U. M. Apte, Type 1 diabetic mice are protected from acetaminophen hepatotoxicity, Toxicol Sci, vol.73, issue.2, pp.220-254, 2003.

T. Wang, K. Shankar, and M. J. Ronis, Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1, J Pharmacol Exp Ther, vol.294, issue.2, pp.473-482, 2000.

R. P. Laguens, S. Candela, and R. E. Hernández, Streptozotocin-induced liver damage in mice, Horm Metab, vol.12, issue.5, pp.197-201, 1980.

Q. Cao, K. M. Mak, and C. S. Lieber, Cytochrome P4502E1 primes macrophages to increase TNFalpha production in response to lipopolysaccharide, Am J Physiol Gastrointest Liver Physiol, vol.289, issue.1, pp.95-107, 2005.

J. L. Hutson and S. N. Wickramasinghe, Expression of CYP2E1 by human monocyte-derived, Pathol, vol.188, issue.2, pp.197-200, 1999.

T. Koivisto, V. M. Mishin, and K. M. Mak, Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells, Alcohol Clin Exp Res, vol.20, issue.2, pp.207-219, 1996.

T. Al-belooshi, J. A. Tariq, and S. , Increased mitochondrial stress and modulation of mitochondrial respiratory enzyme activities in acetaminophen-induced toxicity in mouse macrophage cells, Food Chem Toxicol, vol.48, issue.10, pp.2624-2656, 2010.

Z. Rao, J. Sun, and X. Pan, Hyperglycemia Aggravates Hepatic Ischemia and Reperfusion Injury by Inhibiting Liver-Resident Macrophage M2 Polarization via C/EBP Homologous Protein-Mediated Endoplasmic Reticulum Stress, Front Immunol, vol.8, p.1299, 2017.

Y. Hu, C. Yang, and G. Shen, Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization, Liver Transpl, vol.25, issue.7, pp.1074-90, 2019.

I. Torres-castro, Ú. D. Arroyo-camarena, and C. P. Martínez-reyes, Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose

, Immunol Lett, vol.176, pp.81-90, 2016.

A. Dihingia, D. Ozah, and S. Ghosh, Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose, J Nutr Biochem, vol.52, pp.103-117, 2018.

G. Panahi, P. Pasalar, and M. Zare, High glucose induces inflammatory responses in HepG2 cells via the oxidative stress-mediated activation of NF-?B, and MAPK pathways in HepG2 cells, Arch Physiol Biochem, vol.124, issue.5, pp.468-74, 2018.

J. A. Hinson, J. B. Mays, and A. M. Cameron, Acetaminophen-induced hepatic glycogen depletion and hyperglycemia in mice, Biochem Pharmacol, vol.32, issue.13, pp.1979-88, 1983.

D. V. Ferguson, D. W. Roberts, and H. Han-shu, Acetaminophen-induced alterations in pancreatic beta cells and serum insulin concentrations in B6C3F1 mice, Toxicol Appl Pharmacol, vol.104, issue.2, pp.225-259, 1990.

T. Mezza, F. Cinti, and C. M. Cefalo, ?-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity, Diabetes, vol.68, issue.6, pp.1121-1130, 2019.

K. Begriche, J. Massart, and M. A. Robin, Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease, Hepatology, vol.58, issue.4, pp.1497-507, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00814080

R. S. Khan, F. Bril, and K. Cusi, Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease, Hepatology, vol.70, issue.2, pp.711-735, 2019.

J. Aubert, K. Begriche, and L. Knockaert, Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role, Clin Res Hepatol Gastroenterol, vol.35, issue.10, pp.630-637, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00739365

J. Massart, K. Begriche, and C. Moreau, Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity, J Clin Transl Res, vol.3, issue.1, pp.212-244, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01580159

M. A. Abdelmegeed, S. K. Ha, and Y. Choi, Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances, Curr Mol Pharmacol, vol.10, issue.3, pp.207-232, 2017.

C. Gade, K. Dalhoff, and T. S. Petersen, Higher chlorzoxazone clearance in obese children compared with nonobese peers, Br J Clin Pharmacol, vol.84, issue.8, pp.1738-1785, 2018.

S. Gong, T. Lan, and L. Zeng, Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice, J Hepatol, vol.69, issue.1, pp.51-60, 2018.

K. Moriya, M. Tamai, and T. Koga, Acetaminophen-induced hepatotoxicity of cultured hepatocytes depends on timing of isolation from light-cycle controlled mice, Genes Cells, vol.25, issue.4, pp.257-69, 2020.

S. J. Mitchell, A. E. Kane, and S. N. Hilmer, Age-related changes in the hepatic pharmacology and toxicology of paracetamol, Curr Gerontol Geriatr Res, p.624156, 2011.

M. J. Brill, J. Diepstraten, and A. Van-rongen, Impact of obesity on drug metabolism and elimination in adults and children, Clin Pharmacokinet, vol.51, issue.5, pp.277-304, 2012.

A. Mukherji, S. M. Bailey, and B. Staels, The circadian clock and liver function in health and disease, J Hepatol, vol.71, issue.1, pp.200-211, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02390252

A. Vigliotti, C. Witjes, and J. , Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders, Nat Rev Gastroenterol Hepatol, vol.17, issue.5, pp.279-97, 2020.